Advertisement
Screener

JAGUAR HEALTH, INC. (JAGX) Increase (Decrease) in Other Receivables

2.8 / 5 stars · 68/120 Roast Me

JAGUAR HEALTH, INC. Increase (Decrease) in Other Receivables

JAGUAR HEALTH, INC. (JAGX) reported Increase (Decrease) in Other Receivables of $13.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-19

  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$24.00K.
  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for the quarter ending 2026-03-31 was $37.00K, a 17.78% decline year-over-year.
  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for the quarter ending 2025-12-31 was $108.00K, a 45.95% increase year-over-year.
  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$76.00K.
  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for fiscal 2025 was $45.00K.
  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for fiscal 2024 was -$86.00K.
  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for fiscal 2023 was -$386.00K, a 253.78% decline from fiscal 2022.
  • JAGUAR HEALTH, INC. increase (decrease) in other receivables for fiscal 2022 was $251.00K, a 38.33% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Receivables 3 monthIncrease (Decrease) in Other Receivables 3 month as first filedIncrease (Decrease) in Other Receivables 6 monthIncrease (Decrease) in Other Receivables 6 month as first filedIncrease (Decrease) in Other Receivables 9 monthIncrease (Decrease) in Other Receivables 9 month as first filedIncrease (Decrease) in Other Receivables 12 monthIncrease (Decrease) in Other Receivables 12 month as first filed
2026-06-30-$24.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19
$13.00K
10-Q · filed 2026-08-19
$121.00K
derived: sum of 3 quarters · filed 2026-08-19
$45.00K
derived: sum of 4 quarters · filed 2026-08-19
2026-03-31$37.00K
10-Q · filed 2026-05-20
$145.00K
derived: sum of 2 quarters · filed 2026-05-20
$69.00K
derived: sum of 3 quarters · filed 2026-05-20
$37.00K
derived: sum of 4 quarters · filed 2026-08-19
2025-12-31$108.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07
$32.00K
derived: sum of 2 quarters · filed 2026-04-07
$0.00
derived: sum of 3 quarters · filed 2026-08-19
$45.00K
10-K · filed 2026-04-07
2025-09-30-$76.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$108.00K
derived: sum of 2 quarters · filed 2026-08-19
-$63.00K
10-Q · filed 2025-11-14
$11.00K
derived: sum of 4 quarters · filed 2026-08-19
2025-06-30-$32.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19
$13.00K
10-Q · filed 2026-08-19
$87.00K
derived: sum of 3 quarters · filed 2026-08-19
$73.00K
derived: sum of 4 quarters · filed 2026-08-19
2025-03-31$45.00K
10-Q · filed 2026-05-20
$119.00K
derived: sum of 2 quarters · filed 2026-05-20
$105.00K
derived: sum of 3 quarters · filed 2026-05-20
-$31.00K
derived: sum of 4 quarters · filed 2026-05-20
2024-12-31$74.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-07
$60.00K
derived: sum of 2 quarters · filed 2026-04-07
-$76.00K
derived: sum of 3 quarters · filed 2026-04-07
-$86.00K
10-K · filed 2026-04-07
2024-09-30-$14.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$150.00K
derived: sum of 2 quarters · filed 2025-11-14
-$160.00K
10-Q · filed 2025-11-14
-$129.00K
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30-$136.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$146.00K
10-Q · filed 2025-08-14
-$115.00K
derived: sum of 3 quarters · filed 2025-08-14
-$96.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$10.00K
10-Q · filed 2025-05-15
$21.00K
derived: sum of 2 quarters · filed 2025-05-15
$40.00K
derived: sum of 3 quarters · filed 2025-05-15
-$258.00K
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$31.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$50.00K
derived: sum of 2 quarters · filed 2025-03-31
-$248.00K
derived: sum of 3 quarters · filed 2025-03-31
-$386.00K
10-K · filed 2025-03-31
2023-09-30$19.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
-$279.00K
derived: sum of 2 quarters · filed 2024-11-13
-$417.00K
10-Q · filed 2024-11-13
-$502.00K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$298.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$436.00K
10-Q · filed 2024-08-13
-$521.00K
derived: sum of 3 quarters · filed 2024-08-13
-$385.00K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$138.00K
10-Q · filed 2024-05-14
-$223.00K
derived: sum of 2 quarters · filed 2024-05-14
-$87.00K
derived: sum of 3 quarters · filed 2024-05-14
-$4.00K
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$85.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$51.00K
derived: sum of 2 quarters · filed 2024-04-01
$134.00K
derived: sum of 3 quarters · filed 2024-04-01
$251.00K
10-K · filed 2024-04-01
2022-09-30$136.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$219.00K
derived: sum of 2 quarters · filed 2023-11-14
$336.00K
10-Q · filed 2023-11-14
$677.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$83.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$200.00K
10-Q · filed 2023-08-14
$541.00K
derived: sum of 3 quarters · filed 2023-08-14
$595.00K
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31$117.00K
10-Q · filed 2023-05-15
$458.00K
derived: sum of 2 quarters · filed 2023-05-15
$512.00K
derived: sum of 3 quarters · filed 2023-05-15
$522.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$341.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24
$395.00K
derived: sum of 2 quarters · filed 2023-03-24
$405.00K
derived: sum of 3 quarters · filed 2023-03-24
$407.00K
10-K · filed 2023-03-24
2021-09-30$54.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
$64.00K
derived: sum of 2 quarters · filed 2022-11-14
$66.00K
10-Q · filed 2022-11-14
$91.00K
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22
$12.00K
10-Q · filed 2022-08-22
$37.00K
derived: sum of 3 quarters · filed 2022-08-22
$35.00K
derived: sum of 4 quarters · filed 2022-08-22
2021-03-31$2.00K
10-Q · filed 2022-05-10
$27.00K
derived: sum of 2 quarters · filed 2022-05-10
$25.00K
derived: sum of 3 quarters · filed 2022-05-10
$27.00K
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$23.00K
derived: sum of 2 quarters · filed 2022-03-11
$25.00K
derived: sum of 3 quarters · filed 2022-03-11
$26.00K
10-K · filed 2022-03-11
2020-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-17
$0.00
derived: sum of 2 quarters · filed 2021-11-17
$1.00K
10-Q · filed 2021-11-17
$15.00K
derived: sum of 4 quarters · filed 2021-11-17
2020-06-30$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13
$3.00K
10-Q · filed 2021-08-13
$17.00K
derived: sum of 3 quarters · filed 2021-08-13
-$76.00K
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$1.00K
10-Q · filed 2021-05-17
$15.00K
derived: sum of 2 quarters · filed 2021-05-17
-$78.00K
derived: sum of 3 quarters · filed 2021-05-17
$13.00K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$14.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$79.00K
derived: sum of 2 quarters · filed 2021-03-31
$12.00K
derived: sum of 3 quarters · filed 2021-03-31
$8.00K
10-K · filed 2021-03-31
$7.85K
10-K · filed 2020-04-03
2019-09-30-$93.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16
-$2.00K
derived: sum of 2 quarters · filed 2020-11-16
-$6.00K
10-Q · filed 2020-11-16
-$6.12K
10-Q · filed 2019-11-14
-$176.27K
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$91.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
$87.00K
10-Q · filed 2020-08-13
$86.63K
10-Q · filed 2019-08-14
-$83.27K
derived: sum of 3 quarters · filed 2020-08-13
$22.66K
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31-$4.00K
10-Q · filed 2020-05-15
-$3.82K
10-Q · filed 2019-05-21
-$174.27K
derived: sum of 2 quarters · filed 2020-05-15
-$68.34K
derived: sum of 3 quarters · filed 2020-05-15
-$296.00
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$170.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03
-$64.34K
derived: sum of 2 quarters · filed 2020-04-03
$3.70K
derived: sum of 3 quarters · filed 2020-04-03
$4.74K
10-K · filed 2020-04-03
2018-09-30$105.93K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$173.97K
derived: sum of 2 quarters · filed 2019-11-14
$175.01K
10-Q · filed 2019-11-14
$159.04K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$68.04K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$69.08K
10-Q · filed 2019-08-14
$53.11K
derived: sum of 3 quarters · filed 2019-08-14
-$127.42K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$1.03K
10-Q · filed 2019-05-21
-$14.94K
derived: sum of 2 quarters · filed 2019-05-21
-$195.46K
derived: sum of 3 quarters · filed 2019-05-21
-$285.75K
derived: sum of 4 quarters · filed 2019-05-21
2017-12-31-$15.97K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-10
-$196.50K
derived: sum of 2 quarters · filed 2019-04-10
-$286.79K
derived: sum of 3 quarters · filed 2019-04-10
$1.38K
10-K · filed 2019-04-10
2017-09-30-$180.53K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19
-$270.82K
derived: sum of 2 quarters · filed 2018-11-19
$17.35K
10-Q · filed 2018-11-19
2017-06-30-$90.29K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
$197.88K
10-Q · filed 2018-08-13
2017-03-31$288.17K
10-Q · filed 2018-05-15
-$288.17K
10-Q · filed 2017-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Latigo Biotherapeutics, Inc. (LTGO)United States$1.176B
LB PHARMACEUTICALS INC (LBRX)United States$1.220B-10.87
OPKO HEALTH, INC. (OPK)United States$1.220B-15.59
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
HARROW, INC. (HROW)United States$1.240B-42.77
Damora Therapeutics, Inc. (DMRA)$1.250B-6.10
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Avalyn Pharma Inc. (AVLN)United States$1.267B
First Tracks Biotherapeutics, Inc. (TRAX)United States$1.280B
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02